age-related macular degeneration
PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study
February 14, 2025Clinical Research Opthalmology, age-related macular degeneration, clinical trials
Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
Common diabetes drug can protect against age-related macular degeneration, research shows
October 31, 2018Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma
A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …
Bayer’s challenger to Lucentis shows promise
November 22, 2010Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD
Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
